Vanguard Personalized Indexing Management, LLC Immatics N.V. Transaction History
Vanguard Personalized Indexing Management, LLC
- $9.45 Billion
- Q3 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Immatics N.V. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 47,635 shares of IMTX stock, worth $485,876. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,635
Previous 43,969
8.34%
Holding current value
$485,876
Previous $236,000
71.61%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IMTX
# of Institutions
67Shares Held
93MCall Options Held
53.8KPut Options Held
0-
T. Rowe Price Investment Management, Inc. Baltimore, MD19.4MShares$198 Million0.1% of portfolio
-
Baker Bros. Advisors LP New York, NY12.1MShares$123 Million0.84% of portfolio
-
Suvretta Capital Management, LLC New York, NY12MShares$123 Million3.08% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$95.7 Million0.18% of portfolio
-
Rtw Investments, LP New York, NY8.82MShares$89.9 Million1.0% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $778M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...